FRESENIUS MEDICAL CARE AG Distribution Costs
FRESENIUS MEDICAL CARE AG (FMS) reported Distribution Costs of EUR 618.14 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DistributionCosts · last filed 2026-02-24
- FRESENIUS MEDICAL CARE AG distribution costs for the quarter ending 2025-12-31 was 57.27M EUR, a 27.11% decline year-over-year.
- FRESENIUS MEDICAL CARE AG distribution costs for the quarter ending 2025-09-30 was 186.12M EUR, a 7.09% decline year-over-year.
- FRESENIUS MEDICAL CARE AG distribution costs for the quarter ending 2025-06-30 was 184.25M EUR, a 3.52% decline year-over-year.
- FRESENIUS MEDICAL CARE AG distribution costs for the quarter ending 2025-03-31 was 190.49M EUR, a 0.04% decline year-over-year.
| Period end | Distribution Costs 3 month | Distribution Costs 6 month | Distribution Costs 9 month | Distribution Costs 12 month | Distribution Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 57.27M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 243.39M EUR derived: sum of 2 quarters · filed 2026-02-24 | 427.64M EUR derived: sum of 3 quarters · filed 2026-02-24 | 618.14M EUR 20-F · filed 2026-02-24 | |
| 2025-09-30 | 186.12M EUR 6-K · filed 2025-11-04 | 370.37M EUR derived: sum of 2 quarters · filed 2025-11-04 | 560.87M EUR 6-K · filed 2025-11-04 | 639.44M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2025-06-30 | 184.25M EUR 6-K · filed 2025-08-05 | 374.75M EUR 6-K · filed 2025-08-05 | 453.32M EUR derived: sum of 3 quarters · filed 2026-02-24 | 653.64M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2025-03-31 | 190.49M EUR 6-K · filed 2025-05-06 | 269.06M EUR derived: sum of 2 quarters · filed 2026-02-24 | 469.39M EUR derived: sum of 3 quarters · filed 2026-02-24 | 660.36M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-12-31 | 78.57M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 278.90M EUR derived: sum of 2 quarters · filed 2026-02-24 | 469.87M EUR derived: sum of 3 quarters · filed 2026-02-24 | 660.43M EUR 20-F · filed 2026-02-24 | 776.53M EUR 20-F · filed 2025-02-25 |
| 2024-09-30 | 200.32M EUR 6-K · filed 2025-11-04 | 391.30M EUR derived: sum of 2 quarters · filed 2025-11-04 | 581.86M EUR 6-K · filed 2025-11-04 | 683.18M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | 190.97M EUR 6-K · filed 2025-08-05 | 381.54M EUR 6-K · filed 2025-08-05 | 482.85M EUR derived: sum of 3 quarters · filed 2026-02-24 | 685.11M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | 190.56M EUR 6-K · filed 2025-05-06 | 291.88M EUR derived: sum of 2 quarters · filed 2026-02-24 | 494.13M EUR derived: sum of 3 quarters · filed 2026-02-24 | 693.68M EUR derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | 101.31M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-24 | 303.57M EUR derived: sum of 2 quarters · filed 2026-02-24 | 503.12M EUR derived: sum of 3 quarters · filed 2026-02-24 | 706.40M EUR 20-F · filed 2026-02-24 | 807.96M EUR 20-F · filed 2024-02-20 |
| 2023-09-30 | 202.26M EUR 6-K · filed 2024-11-05 | 401.81M EUR derived: sum of 2 quarters · filed 2024-11-05 | 605.09M EUR 6-K · filed 2024-11-05 | ||
| 2023-06-30 | 199.55M EUR 6-K · filed 2024-07-30 | 402.83M EUR 6-K · filed 2024-07-30 | |||
| 2023-03-31 | 203.28M EUR 6-K · filed 2024-05-07 | ||||
| 2022-12-31 | 800.88M EUR 20-F · filed 2025-02-25 | ||||
| 2021-12-31 | 770.72M EUR 20-F · filed 2024-02-20 |